Clinical and Genomic Characterization of <i>ERBB2</i> -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort

The prevalence of lithiasis seems to be higher in Chilean versus US patients with GBC. A similar prevalence of <i>ERBB2</i> alterations of overall 14% and better OS suggests that a proportion of them could benefit from human epidermal growth factor receptor type 2-targeted therapies. The smaller cohort of Chile, where the disease prevalence is higher, is a reminder and invitation for the need of more robust next-generation sequencing analyses globally.

Authors

Institutions

Publication Details

Journal
JCO Global Oncology
Published
2024-10-01
DOI
https://doi.org/10.1200/go.24.00090
Citations
3
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
1.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical and Genomic Characterization of ERBB2 -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort

Henry S. Walch, Walid K. Chatila, Bruno Nervi, Nikolaus Schultz et al.
3 citations
JCO Global Oncology
Cholangiocarcinoma and Gallbladder Cancer Studies
1.72
article

Clinical and Genomic Characterization of ERBB2 -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort

Henry S. Walch, Walid K. Chatila, Bruno Nervi, Nikolaus Schultz, Patricia Macanas, Bob T. Li, Juan Carlos Roa, Santiago A. Sepúlveda, James J. Harding, Amin Yaqubie, Sebastián Mondaca, Gonzalo Muñoz, Paola Viviani, Claudia Pareja-Barrueto, Ghassan K. Abou‐Alfa, Patricia Garcia
article en
3 citations

Abstract

The prevalence of lithiasis seems to be higher in Chilean versus US patients with GBC. A similar prevalence of <i>ERBB2</i> alterations of overall 14% and better OS suggests that a proportion of them could benefit from human epidermal growth factor receptor type 2-targeted therapies. The smaller cohort of Chile, where the disease prevalence is higher, is a reminder and invitation for the need of more robust next-generation sequencing analyses globally.

JCO Global OncologyVol. 10(10)
Memorial Sloan Kettering Cancer Center (US), Pontificia Universidad Católica de Chile (CL), Trinity College Dublin (IE), Cornell University (US), Molecular Oncology (United States) (US)
Conquer Cancer Foundation, Memorial Sloan-Kettering Cancer Center, Cycle for Survival, European Commission, Agencia Nacional de Investigación y Desarrollo, National Institutes of Health, Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
Partnerships for the goals
Openalex Percentile: Top 15%
Cholangiocarcinoma and Gallbladder Cancer Studies
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.